AstraZeneca halts vaccine trials in children over blood clot fears in young people

An Oxford University spokesperson has said the move was precautionary, stating that they have yet to uncover any health issues among the young people involved in the trial. The vaccine trial at Oxford University involved five-to-17-year-olds and had been running since February 2021. A Wall Street Journal report claims the University halted their trial and are now awaiting advice from the UK’s regulator, the Medicines and Healthcare products Regulatory Agency.

More to follow…

More Stories
Prince Philip dies: Westminster Abbey to toll bell every 60 seconds, 99 times in tribute